This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Lexicon Pharmaceuticals Inc (LXRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 202.99M 137.27M 37.50M 30.42M
Receivables 911.00K 1.03M 790.00K 1.38M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 23.85M 0.00 0.00
Total Current Assets 532.40M 368.99M 134.55M 230.94M
Property, Plant & Equipment, Gross 80.66M 37.35M 123.31M 126.05M
Accumulated Depreciation & Depletion 59.43M 36.27M 81.94M 83.42M
Property, Plant & Equipment, Net 21.23M 1.08M 41.36M 42.63M
Intangibles 53.36M 53.36M 53.56M 53.56M
Other Non-Current Assets 3.31M 3.41M 144.00K 109.00K
Total Non-Current Assets 122.43M 102.39M 139.61M 140.84M
Liabilities & Shareholder Equity
Total Assets 654.83M 471.38M 274.16M 371.78M
Accounts Payable 19.73M 13.06M 9.71M 7.66M
Short Term Debt 2.02M 20.17M 1.71M 1.57M
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 123.00M 44.97M 19.29M 18.29M
Long Term Debt 103.79M 87.50M 20.17M 21.88M
Deferred Income Taxes 18.68M 18.68M 18.75M 18.75M
Other Non-Current Liabilities 123.52M 36.21M 45.79M 46.19M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 245.99M 142.39M 84.70M 86.81M
Total Liabilities 368.98M 187.36M 104.00M 105.10M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 285.85M 284.02M 170.16M 266.68M
Common Par 104.00K 726.00K 514.00K 512.00K
Additional Paid In Capital 1.40B 1.39B 1.18B 1.17B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.11B -1.10B -1.00B -899.83M
Treasury Stock -2.75M -2.39M -1.50M -630.00K
Other Equity Adjustments -219.00K -63.00K 2.00K 23.00K
Total Capitalization 389.64M 371.52M 190.33M 288.56M
Total Equity 285.85M 284.02M 170.16M 266.68M
Total Liabilities & Stock Equity 654.83M 471.38M 274.16M 371.78M
Total Common Shares Outstanding 103.62M 103.48M 73.36M 73.20M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 237.00K 26.14K 16.61K 7.75K
Basic Weighted Shares Outstanding 103.59M 76.35M 73.30M 69.96M
Diluted Weighted Shares Outstanding 103.59M 76.35M 73.30M 69.96M
Number of Employees 120 106 149 230
Number of Part-Time Employees 0 0 0 0
LXRX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

LXRX Lexicon Pharmaceuticals Inc

Chart of LXRX

Analysts Ratings for LXRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET LXRX ANALYST REPORT

LXRX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs